Introducing baselines for therapeutic use of regulatory T cells and cytokines in autoimmunity.
about
Opinion: Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetesAntigen-specific induction of regulatory T cells for type 1 diabetes therapy.Regulatory T cells in patients with inflammatory bowel diseases treated with adacolumn granulocytapheresis.Manipulation of regulatory T-cell function by immunomodulators: a boon or a curse?Effects of polyinosinic-polycytidylic acid and adoptive transfer of immune cells in the Lew.1AR1-iddm rat and in its coisogenic LEW.1AR1 background strain.
P2860
Introducing baselines for therapeutic use of regulatory T cells and cytokines in autoimmunity.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Introducing baselines for ther ...... and cytokines in autoimmunity.
@ast
Introducing baselines for ther ...... and cytokines in autoimmunity.
@en
type
label
Introducing baselines for ther ...... and cytokines in autoimmunity.
@ast
Introducing baselines for ther ...... and cytokines in autoimmunity.
@en
prefLabel
Introducing baselines for ther ...... and cytokines in autoimmunity.
@ast
Introducing baselines for ther ...... and cytokines in autoimmunity.
@en
P356
P1433
P1476
Introducing baselines for ther ...... and cytokines in autoimmunity
@en
P2093
Matthias von Herrath
P304
P356
10.1016/J.IT.2003.08.004
P50
P577
2003-10-01T00:00:00Z